ROBERTSON GLOBAL HEALTH SOLUTIONS CORP

CIK:0000007951|SEC Filings

Consolidated Statements of Operations (USD $)	12 Months Ended		90 Months Ended
Consolidated Statements of Operations (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Revenues
Contract fees		$ 10,000	$ 143,000
Contract fees - related party		207,416	207,416
Total revenues		217,416	350,416
Operating expenses
Cost of revenues			139,536
Product and content development	264,543	1,004,352	6,812,852
Selling, general and administrative	798,610	1,902,019	9,355,315
Impairment expense on real estate held for sale			1,548,375
Total operating expenses	1,063,153	2,906,371	17,856,078
Operating loss	(1,063,153)	(2,688,955)	(17,505,662)
Other income (expense)
Unrealized gain on derivative revaluation			17,279
Interest and other income	12,000	38,390	360,624
Gain on disposal of assets	60		60
Other expenses		(3,964)	(97,236)
Interest expense	(147,587)	(153,874)	(849,892)
Total other income (expense)	(135,527)	(119,448)	(569,165)
Net loss	$ (1,198,680)	$ (2,808,403)	$ (18,074,827)
Loss per share (basic and diluted) (in Dollars per share)	$ (0.10)	$ (0.24)
Weighted average number of common shares outstanding (basic and diluted) (in Shares)	12,601,285	11,664,382

Consolidated Statements of Cash Flows (USD $)	12 Months Ended		90 Months Ended
Consolidated Statements of Cash Flows (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Operating activities
Net loss	$ (1,198,680)	$ (2,808,403)	$ (18,074,827)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation	2,022	1,866	46,066
Amortization of deferred rent and facility exit liability	(32,329)	(50,911)	(97,613)
Adjustment of accrued facility exit liability		1,085	31,038
Unrealized gain on derivative revaluation			(17,279)
Impairment expense			1,548,375
(Gain) loss on sale of assets	(60)	2,878	2,818
Gain on debt cancellation			(262,088)
Note discount accretion		27,003	128,413
Beneficial conversion of convertible debt			89,048
Value of warrants issued for note guarantee			16,384
Stock based compensation	184,539	656,353	1,149,494
Changes in:
Accounts receivable	41,500	(41,500)
Accounts receivable - related parties	(45,563)	(38,189)	(86,994)
Prepaid and other	(8,397)	(8,395)	(36,783)
Accounts payable and accrued expenses	385,932	891,701	4,399,354
Deposits		(3,747)	(3,747)
Deferred revenue	16,667	(175,916)	48,167
Accrued interest	119,546	94,772	429,697
Net cash used by operating activities	(534,823)	(1,451,403)	(10,690,477)
Investing activities
Purchase of property and equipment	(1,346)	(6,240)	(53,555)
Proceeds from sale of assets		543,747	843,747
Cash received in merger transaction			243,296
Net cash provided by investing activities	(1,346)	537,507	1,033,488
Financing activities
Net change in stockholder advances	60,000		210,000
Sale of common stock	345,000	620,000	8,877,500
Sale of warrants		178,375	178,375
Repurchase of common stock			(372,000)
Payment of fractional shares			(4,321)
Proceeds from exercise of warrants		75,000	75,000
Proceeds from exercise of stock options		1,800	1,800
Proceeds from issuance of debt	140,000	275,000	1,335,416
Repayment of debt	(93,652)	(186,670)	(639,017)
Net cash provided by financing activities	451,348	963,505	9,662,753
Net increase (decrease) in cash	(84,821)	49,609	5,764
Cash, beginning of period	90,585	40,976
Cash, end of period	5,764	90,585	5,764
SUPPLEMENTAL CASH-FLOW INFORMATION
Cash paid for interest	28,041	32,099	210,575
Transfers of liabilities from affiliate for costs incurred			824,053
Derivative liability recorded for warrants			17,279
Issuance of debt in redemption of accrued liabilities	103,867	180,373	909,872
Repayment of advances from proceeds from sale of assets		150,000	150,000
Issuance of stock on conversion of debt		348,218	741,215
Non-cash payment on accounts payable	$ 725		$ 725

Consolidated Balance Sheets (USD $)	Sep. 30, 2012	Sep. 30, 2011
Current assets
Cash	$ 5,764	$ 90,585
Accounts receivable		41,500
Prepaid and other	44,060	35,663
Total current assets	49,824	167,748
Property and equipment, net	7,147	8,487
Accounts receivable - related parties	92,594	47,031
Total assets	149,565	223,266
Current liabilities
Accounts payable	1,075,467	978,152
Accrued interest	327,254	207,707
Accrued other liabilities	856,113	672,088
Deferred revenue	48,167	31,500
Stockholder advances	60,000
Notes payable related parties - net	846,275	655,675
Notes payable other - net	530,068	520,449
Current portion of facility exit liability		32,329
Current portion bank term note	50,000	50,000
Total current liabilities	3,793,344	3,147,900
Long-term debt
Bank term note	87,491	137,495
Total long-term debt	87,491	137,495
Total liabilities	3,880,835	3,285,395
Stockholders' deficit
Preferred stock, $0.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $0.001 par value, authorized 20,000,000, 13,042,187 and 12,352,187 shares issued and outstanding, respectively	13,042	12,352
Paid-in capital	14,330,515	13,801,666
Deficit accumulated during development stage	(18,074,827)	(16,876,147)
Total stockholders' deficit	(3,731,270)	(3,062,129)
Total liabilities and stockholders' deficit	$ 149,565	$ 223,266